The approval of COVID-19 vaccines may have been fast-tracked, but these medicines were still subject to rigorous checks carried out by regulatory authorities.
Breakdown
- Claims have resurfaced online that the European Commission approved COVID-19 vaccines without proper checks. 8s
- The Commission explained that vaccines received conditional marketing authorisations, a standard practice in public health emergencies. 45s
- Conditional authorisations allow earlier access to medicines when full data is not yet available, as previously used for the Ebola vaccine. 1m 9s
- COVID-19 vaccines underwent large clinical trials and met European Medicines Agency standards before receiving full authorisation. 1m 29s
- Vaccine monitoring continues after full authorisation, and approvals can be withdrawn if needed. 1m 48s